James Mather

432 total citations
8 papers, 306 citations indexed

About

James Mather is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, James Mather has authored 8 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Physiology and 2 papers in Surgery. Recurrent topics in James Mather's work include Asthma and respiratory diseases (4 papers), Amyotrophic Lateral Sclerosis Research (2 papers) and Respiratory and Cough-Related Research (2 papers). James Mather is often cited by papers focused on Asthma and respiratory diseases (4 papers), Amyotrophic Lateral Sclerosis Research (2 papers) and Respiratory and Cough-Related Research (2 papers). James Mather collaborates with scholars based in United States, United Kingdom and Netherlands. James Mather's co-authors include George S. Athwal, Joy C. MacDermid, Kenneth J. Faber, Michael Bozik, Evan W. Ingersoll, Valentin K. Gribkoff, Donald Archibald, Hiroshi Mitsumoto, Dan H. Moore and Merit Cudkowicz and has published in prestigious journals such as Nature Medicine, Journal of Allergy and Clinical Immunology and Journal of Shoulder and Elbow Surgery.

In The Last Decade

James Mather

8 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Mather United States	5	148	86	79	64	63	8	306
Fernando Guerrero‐Pérez Spain	9	33 0.2×	59 0.7×	147 1.9×	42 0.7×	56 0.9×	38	300
Chao Peng China	9	106 0.7×	28 0.3×	88 1.1×	46 0.7×	59 0.9×	21	272
Trenton Lippert United States	13	65 0.4×	89 1.0×	72 0.9×	130 2.0×	88 1.4×	26	420
Jeong Taik Kwon South Korea	11	131 0.9×	19 0.2×	142 1.8×	44 0.7×	69 1.1×	25	355
Şükrü Aykol Türkiye	11	133 0.9×	16 0.2×	149 1.9×	20 0.3×	62 1.0×	26	375
Margaret L. Jackson United States	7	66 0.4×	65 0.8×	105 1.3×	100 1.6×	51 0.8×	10	312
Gildo Matta Italy	11	49 0.3×	338 3.9×	55 0.7×	85 1.3×	28 0.4×	13	627
Lucy Brazil United Kingdom	6	81 0.5×	78 0.9×	75 0.9×	38 0.6×	125 2.0×	13	274
Lorenzo Peverelli Italy	11	124 0.8×	85 1.0×	32 0.4×	229 3.6×	23 0.4×	26	393
A Radek Poland	10	52 0.4×	22 0.3×	131 1.7×	59 0.9×	67 1.1×	61	315

Countries citing papers authored by James Mather

Since Specialization

Citations

This map shows the geographic impact of James Mather's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Mather with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Mather more than expected).

Fields of papers citing papers by James Mather

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Mather. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Mather. The network helps show where James Mather may publish in the future.

Co-authorship network of co-authors of James Mather

This figure shows the co-authorship network connecting the top 25 collaborators of James Mather. A scholar is included among the top collaborators of James Mather based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Mather. James Mather is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Siddiqui, Salman, Sally E. Wenzel, Michael Bozik, et al.. (2023). Safety and Efficacy of Dexpramipexole in Eosinophilic Asthma (EXHALE): A randomized controlled trial. Journal of Allergy and Clinical Immunology. 152(5). 1121–1130.e10. 12 indexed citations

Prussin, Calman, Michael Bozik, James Mather, et al.. (2022). The Oral Eosinophil-lowering Drug Dexpramipexole Improves FEV1 Largely Thorough its Effect on FVC. Journal of Allergy and Clinical Immunology. 149(2). AB18–AB18. 2 indexed citations

Siddiqui, Salman, Michael Bozik, Donald Archibald, et al.. (2021). Late Breaking Abstract - Phase 2 trial evaluating the effects of dexpramipexole on blood eosinophils, lung function, and airway biomarkers in eosinophilic asthma. RCT2900–RCT2900. 3 indexed citations

Prussin, Calman, Reynold A. Panettieri, Michael Bozik, et al.. (2021). Oral Dexpramipexole Efficacy in Lowering Blood Eosinophils in Patients with Moderate to Severe Uncontrolled Eosinophilic Asthma: Study Design and Baseline Data from the AS201 Phase 2 Trial. A1359–A1359. 2 indexed citations

Bozik, Michael, Hiroshi Mitsumoto, Benjamin Rix Brooks, et al.. (2014). A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 15(5-6). 406–413. 39 indexed citations

Mather, James, Joy C. MacDermid, Kenneth J. Faber, & George S. Athwal. (2012). Proximal humerus cortical bone thickness correlates with bone mineral density and can clinically rule out osteoporosis. Journal of Shoulder and Elbow Surgery. 22(6). 732–738. 92 indexed citations

Cudkowicz, Merit, Michael Bozik, Evan W. Ingersoll, et al.. (2011). The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis. Nature Medicine. 17(12). 1652–1656. 132 indexed citations

Bozik, Michael, James Mather, William G. Kramer, Valentin K. Gribkoff, & Evan W. Ingersoll. (2010). Safety, Tolerability, and Pharmacokinetics of KNS-760704 (Dexpramipexole) in Healthy Adult Subjects. The Journal of Clinical Pharmacology. 51(8). 1177–1185. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact